Aldosterone escape during blockade of the renin–angiotensin–aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate
暂无分享,去创建一个
[1] H. Parving,et al. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? , 2003, Diabetes care.
[2] Koichi Hayashi,et al. Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy , 2003, Hypertension.
[3] V. Buckalew,et al. OR-54: Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria , 2002 .
[4] M. Epstein,et al. Aldosterone as a Determinant of Cardiovascular and Renal Dysfunction , 2001, Journal of the Royal Society of Medicine.
[5] S. Anker,et al. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. , 2001, Journal of the American College of Cardiology.
[6] M Epstein,et al. Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift , 2001, Journal of hypertension.
[7] N. Hollenberg,et al. Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. , 2001, Kidney international.
[8] S. Yusuf,et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. , 1999, Circulation.
[9] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[10] K J Rothman,et al. No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.